Cargando…
GNE myopathy: History, etiology, and treatment trials
GNE myopathy is an ultrarare muscle disease characterized by slowly progressive muscle weakness. Symptoms typically start in early adulthood, with weakness and atrophy in the tibialis anterior muscles and with slow progression over time, which largely spares the quadriceps muscles. Muscle biopsy sho...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623016/ https://www.ncbi.nlm.nih.gov/pubmed/36330422 http://dx.doi.org/10.3389/fneur.2022.1002310 |
_version_ | 1784821898603921408 |
---|---|
author | Mullen, Jeffrey Alrasheed, Khalid Mozaffar, Tahseen |
author_facet | Mullen, Jeffrey Alrasheed, Khalid Mozaffar, Tahseen |
author_sort | Mullen, Jeffrey |
collection | PubMed |
description | GNE myopathy is an ultrarare muscle disease characterized by slowly progressive muscle weakness. Symptoms typically start in early adulthood, with weakness and atrophy in the tibialis anterior muscles and with slow progression over time, which largely spares the quadriceps muscles. Muscle biopsy shows atrophic fibers and rimmed vacuoles without inflammation. Inherited in an autosomal recessive manner, patients with GNE myopathy carry mutations in the GNE gene which affect the sialic acid synthesis pathway. Here, we look at the history and clinical aspects of GNE myopathy, as well as focus on prior treatment trials and challenges and unmet needs related to this disorder. |
format | Online Article Text |
id | pubmed-9623016 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96230162022-11-02 GNE myopathy: History, etiology, and treatment trials Mullen, Jeffrey Alrasheed, Khalid Mozaffar, Tahseen Front Neurol Neurology GNE myopathy is an ultrarare muscle disease characterized by slowly progressive muscle weakness. Symptoms typically start in early adulthood, with weakness and atrophy in the tibialis anterior muscles and with slow progression over time, which largely spares the quadriceps muscles. Muscle biopsy shows atrophic fibers and rimmed vacuoles without inflammation. Inherited in an autosomal recessive manner, patients with GNE myopathy carry mutations in the GNE gene which affect the sialic acid synthesis pathway. Here, we look at the history and clinical aspects of GNE myopathy, as well as focus on prior treatment trials and challenges and unmet needs related to this disorder. Frontiers Media S.A. 2022-10-18 /pmc/articles/PMC9623016/ /pubmed/36330422 http://dx.doi.org/10.3389/fneur.2022.1002310 Text en Copyright © 2022 Mullen, Alrasheed and Mozaffar. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Mullen, Jeffrey Alrasheed, Khalid Mozaffar, Tahseen GNE myopathy: History, etiology, and treatment trials |
title | GNE myopathy: History, etiology, and treatment trials |
title_full | GNE myopathy: History, etiology, and treatment trials |
title_fullStr | GNE myopathy: History, etiology, and treatment trials |
title_full_unstemmed | GNE myopathy: History, etiology, and treatment trials |
title_short | GNE myopathy: History, etiology, and treatment trials |
title_sort | gne myopathy: history, etiology, and treatment trials |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623016/ https://www.ncbi.nlm.nih.gov/pubmed/36330422 http://dx.doi.org/10.3389/fneur.2022.1002310 |
work_keys_str_mv | AT mullenjeffrey gnemyopathyhistoryetiologyandtreatmenttrials AT alrasheedkhalid gnemyopathyhistoryetiologyandtreatmenttrials AT mozaffartahseen gnemyopathyhistoryetiologyandtreatmenttrials |